FDA to get tougher on ads
Agency vows to police one-sided drug claims, urges informed public
WASHINGTON -- Citing the boom-bust history of Celebrex and Vioxx, blockbuster drugs that jeopardized the health of thousands, the Food and Drug Administration says it will be more vigilant in monitoring drug advertising to consumers. (Full article: 914 words)
This article is available in our archives:
Globe Subscribers
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly





